This Article Full Text (OnlineFirst PDF) All Versions of this Article: 1352458508095921v1 15/1/96    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Köpke, S Articles by Heesen, C Search for Related Content PubMed PubMed Citation Articles by Köpke, S Articles by Heesen, C Social Bookmarking                         What's this?

Patient education program to enhance decision autonomy in multiple sclerosis relapse management: a randomized-controlled trial

¹ Unit of Health Sciences and Education, University of Hamburg, Hamburg, Germany
² GEB, Gesellschaft für Empirische Beratung mbH, Denzlingen, Germany
³ Institute for Neuroimmunology and Clinical MS Research (INiMS), University Medical Center Hamburg-Eppendorf, Hamburg, Germany

^* To whom correspondence should be addressed.

	Abstract

Background

Contrary to strong recommendations for high-dose intravenous corticosteroid treatment for relapses in multiple sclerosis (MS), uncertainty remains about most aspects of relapse management. Oral corticosteroids administered by physicians or patients themselves or no corticosteroids also appear justifiable.

Objective

To evaluate an education program that aims to involve patients with MS in decisions on relapse management.

Methods

In three German MS centers, 150 patients with relapsing MS were randomly assigned to a single, 4-h group session or a standard information leaflet. The primary outcome measure was the proportion of relapses with oral or no corticosteroid therapy as an indicator of patient autonomy in treatment decision making. Other outcomes included perceived decision autonomy, quality of life, and disability status.

Results

In the intervention group (IG), 108/139 (78%) relapses were treated with oral or no corticosteroids compared with 101/179 (56%) in the control group; P < 0.0001. Patients' perceived autonomy of treatment decision making was significantly higher in the IG; P < 0.0001. Quality of life, disability status, and adverse events of corticosteroid therapies were comparable.

Conclusion

The patient education program led to more autonomous decision making in patients with relapsing MS. Relevant changes in relapse management were observed.

Key Words: decision making, decision support technique, glucocorticoids, multiple sclerosis, patient education, patient participation

First published on October 9, 2008, doi:10.1177/1352458508095921

Multiple Sclerosis 2009;15:96.

A more recent version of this article appeared on January 1, 2009


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				C Heesen, N Schaffler, J Kasper, I Muhlhauser, and S Kopke Suspected multiple sclerosis - what to do? Evaluation of a patient information leaflet Multiple Sclerosis, September 1, 2009; 15(9): 1103 - 1112. [Abstract] [PDF]